Ulcerated Perianal Infantile Hemangioma Treated with Propranolol.
- Author:
Sang Jin OH
1
;
Han Eul LEE
;
Jong Suk LEE
;
Sung Yul LEE
;
Kyung Bae PARK
Author Information
1. Department of Dermatology, College of Medicine, Soonchunhyang University, Cheonan, Korea. dermsung@schmc.ac.kr
- Publication Type:Case Report
- Keywords:
Propranolol;
Ulcerative infantile hemangioma
- MeSH:
Adrenal Cortex Hormones;
Child;
Cicatrix;
Hemangioma;
Hemorrhage;
Humans;
Propranolol;
Ulcer
- From:Korean Journal of Dermatology
2013;51(2):155-157
- CountryRepublic of Korea
- Language:English
-
Abstract:
Infantile hemangioma is a self-resolving benign tumor that commonly requires no intervention. Despite its distinctive, self-limiting course, infantile hemangiomas may result in ulcerations that cause pain, potential scarring, bleeding, and infection. Active treatment is usually required to manage these lesions. The discovery of propranolol in the treatment of infantile hemangioma was described in 2008 by Leaute-Labreze, et al. Since then, its effectiveness and safety have been confirmed by several cases, and replacing systemic corticosteroids as a first-line therapy. Herein, we report the successful treatment of children with ulcerated perianal infantile hemangioma with propranolol.
